Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

What's most interesting from those fiscal Q4 Bloomberg numbers is that reported sales for both FocalinXR and SeroquelXR were higher.

So we "should" see higher fiscal Q4 revenues reported for IPCI after all unless those Bloomberg numbers are so completely off base they should no longer be relied upon for any attempted speculative guesswork whatsoever right!

Plus with PAR finally launching the 5mg and 40mg FocalinXR strengths...the fiscal Q1 FocalinXR revenue numbers for IPCI should receive a slight bump as well.

So IPCI may just exceed $2M in reported fiscal Q4 revenue and report a YOY revenue increase from $2M in 2016 to somewhere north of +$6.5M in 2017...and may just be on track for 2018 revenue of somewhere north of +$12M from just ongoing SeroquelXR and FocalinXR sales.

In other words the dark days may soon be behind us and everything we hoped would occur over these past 4 years will finally start to occur next year forward glta